Imagen de Portada

Pharmacokinetics and Bioequivalence of a Generic Ticagrelor 90‐mg Formulation Versus the Innovator Product in Healthy White Subjects Under Fasting Conditions

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Simona Rizea‐Savu, Simona Nicoleta Duna, Adrian Ghita, Adriana Iordachescu, Ioana Garlea, Marinela Chirila
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical Pharmacology in Drug Development
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Vildagliptin in Healthy Chinese Subjects
por: Mengli Tian, et al.
Publicado: (2024)

The Bioequivalence of Abexinostat (CRA‐024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting Conditions
por: Xiang Li, et al.
Publicado: (2024)

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
por: Yu‐Ying Xu, et al.
Publicado: (2025)

Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
por: Yuan Liu, et al.
Publicado: (2025)

Pharmacokinetic and Bioequivalence Evaluation of Ulipristal Acetate in Healthy Chinese Subjects in the Fasting and Postprandial Conditions
por: Ling He, et al.
Publicado: (2025)

Comparative Pharmacokinetics and Bioequivalence of 2 Formulations of Bosentan Dispersible Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
por: Zhaoming Huang, et al.
Publicado: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
por: Biao Sun, et al.
Publicado: (2026)

Bioequivalence and Food Effect Assessment Between 2 Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Chinese Subjects
por: Kaixian Tang, et al.
Publicado: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects
por: Juan Jin, et al.
Publicado: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects
por: Huan Song, et al.
Publicado: (2025)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions
por: Yanrong Wang, et al.
Publicado: (2024)

Bioequivalence Study of Atenolol Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
por: Yongtao Li, et al.
Publicado: (2024)

Pharmacokinetic and Bioequivalence Evaluation of Two Sitagliptin Tablets With Different Salts in Healthy Subjects
por: Usok Hyun, et al.
Publicado: (2025)

Bioequivalence and Pharmacokinetics of Ibuprofen Extended‐Release Capsules in Healthy Chinese Volunteers Under Fasting and Postprandial Conditions
por: Mingqi Chen, et al.
Publicado: (2025)

Bioequivalence Analysis of Clindamycin Hydrochloride Capsules in Healthy Chinese Subjects Under Fasted and Fed Conditions
por: Zhi Wang, et al.
Publicado: (2024)

A Bioequivalence Trial of Lenvatinib Mesylate Capsules in Healthy Subjects Under Fasting and Postprandial Conditions
por: Junbo Shao, et al.
Publicado: (2024)

Bioequivalence Assessment of Two Dapoxetine Hydrochloride Formulations in Healthy Chinese Males Under Fasted and Fed Conditions
por: Yumin Li, et al.
Publicado: (2024)

Bioequivalence Study of Two Olopatadine Hydrochloride Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions
por: Yuyan Lei, et al.
Publicado: (2025)

Pharmacokinetic and Bioequivalence Evaluation of Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate, and Aspirin Tablets in Healthy Chinese Subjects in the Fasting and Postprandial Conditions
por: Fang Yao, et al.
Publicado: (2024)

Comparative Pharmacokinetics and Bioequivalence Assessment of Metformin/Pioglitazone Tablet in Fasting and Fed Conditions: A Randomized Study in Healthy Chinese Subjects
por: Hongcheng Li, et al.
Publicado: (2026)

Pharmacokinetics and Bioequivalence of Vardenafil Hydrochloride in Healthy Chinese Volunteers
por: Sheng He, et al.
Publicado: (2024)

Pharmacokinetics and Bioequivalence of two Empagliflozin Tablet Formulations: Results From a Randomized, Open‐Label, Crossover Study in Fasting Healthy Volunteers
por: Kar Ming Yee, et al.
Publicado: (2025)

Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open‐Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers
por: Chuei Wuei Leong, et al.
Publicado: (2024)

Single‐Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non‐Pregnant, Non‐Lactating Premenopausal Female Subjects Under Fasting Conditions
por: Sudershan Kumar, et al.
Publicado: (2026)

Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults
por: Huizi Zhang, et al.
Publicado: (2024)

Bioequivalence and Tolerability of 2 Lurasidone Formulations: A Randomized, Single‐Dose, 2‐Period, Crossover Study in Healthy Chinese Subjects Under Fasting and Fed Conditions
por: Hengyi Yu, et al.
Publicado: (2025)

Comparison of the Pharmacokinetics of Three Budesonide Formulations in Healthy Chinese Subjects
por: Tengrui Yin, et al.
Publicado: (2025)

A Randomized, Open‐Label, Two‐Sequence, Crossover Trial Evaluating the Bioequivalence, and Pharmacokinetics of Two Sulfamethoxazole/Trimethoprim Tablet Formulations in Healthy Chinese Volunteers Under Fasting Conditions
por: Xueqiong Peng, et al.
Publicado: (2025)

Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
por: Zhaoyu Wang, et al.
Publicado: (2024)

Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State
por: Shengling Hu, et al.
Publicado: (2024)

A Bioequivalence Study of Azilsartan in Healthy Chinese Subjects
por: Xiaobei Liu, et al.
Publicado: (2024)

Bioequivalence of a Donepezil/Memantine 10/20 mg Fixed‐Dose Combination Versus Single‐Component Tablets in Healthy Korean Males
por: Minkyu Choi, et al.
Publicado: (2025)

Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study
por: Chenning Zhang, et al.
Publicado: (2024)

Comparative Pharmacodynamic Bioequivalence Study of Enoxaparin Sodium 100 mg/1 mL Solution for Injection in Prefilled Syringe in Healthy Volunteers Under Fasting Conditions
por: Naba Kumar Talukdar, et al.
Publicado: (2025)

Comparative Bioequivalence Study of 2 Clopidogrel 75‐mg Tablet Formulations in Moroccan Volunteers
por: Aimen El Orche, et al.
Publicado: (2024)

Bioequivalence Study of Bedaquiline Fumarate Tablets in Healthy Chinese Subjects
por: Man Yang, et al.
Publicado: (2025)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
por: Pan Luo, et al.
Publicado: (2026)

Bioequivalence and Pharmacokinetic Evaluation of Gliclazide Modified‐Release Tablets in Healthy Chinese Volunteers
por: Kejia Fu, et al.
Publicado: (2026)

Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
por: Sergei Noskov, et al.
Publicado: (2024)

Bioequivalence Study of 2 Formulations of Fluticasone Nasal Spray in Healthy Chinese Volunteers
por: Gang Chen, et al.
Publicado: (2025)